Issue №6-22, 2023

Original article

https://doi.org/10.38025/2078-1962-2023-22-6-21-27

Biofeedback Endurance Training for Gait Rehabilitation in Parkinson’s Disease: a Non-Randomized Controlled Study

View article (Download PDF file)



Download XML file

1 ORCID Olga V. Guseva, 1 ORCIDNatalia G. Zhukova

1Siberian State Medical University


ABSTRACT

INTRODUCTION. Parkinson’s disease is a disease with the highest rates of disability growth in the neurodegenerative pathology group, with the leading motor symptom — impaired walking and an increased risk of falling. There is evidence that Parkinson’s disease preserves stability for cycling. The issue of extending the effects of cycling training to daily activity, including walking, remains unclear.

AIM. To evaluate the effect of a course of endurance training on a cycle ergometer with biofeedback (BFB) on a walking ability of a patient with Parkinson’s disease.

MATERIALS AND METHODS. A total of 69 patients with stages 2–3 Parkinson’s disease according to the Hoehn and Yahr Rating Scale were included in the study, group 1: 34 people (60.05 ± 7.07 years) and group 2: 35 patients (61.75 ± 7.53 years). The patients were examined — anamnesis collection: duration of Parkinson disease, presence of arterial hypertension (AH), sports history, medication, assessment of systolic and diastolic blood pressure (SBP and DBP), body mass index (BMI), “6-minute walk” test (6MWT), motor function according to the MDS UPDRS scale — part III. The patients of group 1 had daily exercises on a digital bicycle ergometer with BOS for 10 days, the patients of group 2 — therapeutic gymnastics. The therapy was assessed by repeated 6MWT.

RESULTS AND DISCUSSION. The Parkinson’s disease duration was longer in the patients of group 1. Concomitant hypertension was in 20 (57 %) patients of group 1 and 16 (47 %) patients of group 2 (p > 0.05). 11 people of group 1 and 5 of group 2 had a sports history (p = 0.07). The indicators of SBP and DBP of groups 1 and 2 had normal values during the examination. BMI in both groups corresponded to excess body weight. Patients had risk factors of the modern world: hypertension and overweight. Motor disorders according to the MDS UPDRS — Part III scale were greater in group 1. Despite having serious motor impairments in group 1, after the therapy, the patients demonstrated an increase in the distance traveled in 6 minutes (392.18 ± 96.3 m vs. 476.43 ± 108.08 m; p < 0.05), while no changes were found in group 2.

CONCLUSION. BOS endurance training on a cycle ergometer is effective for walking rehabilitation of Parkinson’s disease patients.


KEYWORDS: Parkinson’s disease, walking, biofeedback, endurance, 6-minute walk test

Acknowledgments: The study had no sponsorship.

Conflict of interest:: The authors declare no apparent or potential conflicts of interest related to the publication of this article.

For citation: Guseva O.V., Zhukova N.G. Biofeedback Endurance Training for Gait Rehabilitation in Parkinson’s Disease: a Non-Randomized Controlled Study. Bulletin of Rehabilitation Medicine. 2023; 22(6):21-27. https://doi.org/10.38025/2078-1962-2023-22-6-21-27 (In Russ.).

Для корреспонденции: Olga V. Guseva, E-mail: guseva.ov@ssmu.ru



Список литературы:

  1. Michael B., Ellul M. Global, regional, and national burden of neurological disorders. 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. Neurology. 2019; 8(5): 459–480. https://doi.org/10.1016/S1474-4422(18)30499-X
  2. Launch of WHO’s Parkinson disease technical brief. WHO. 2022. https://www.who.int/news/item/14-06-2022-launch-of-who-s-parkinson-disease-technical-brief (accessed on: 17.06.2023)
  3. Bloem B.R., Okun M.S., Klein C. Parkinson’s disease. Lancet. 2021; 387(10291): 2284–2303. https://doi.org/10.1016/s0140-6736(21)00218-x
  4. Fothergill-Misbah N., Walker R., Kwasa J. et al. “Old people problems”, uncertainty and legitimacy: Challenges with diagnosing Parkinson’s disease in Kenya. Social Science & Medicine. 2021; 114148. https://doi.org/10.1016/j.socscimed.2021.114148
  5. Bloem B.R., Henderson E.J., Dorsey E.R. et al. Integrated and patient-centred management of Parkinson’s disease: a network model for reshaping chronic neurological care. Lancet. Neurology. 2020; 19(7): 623–634. https://doi.org/10.1016/S1474-4422(20)30064-8
  6. Dijkstra B.W., Gilat M., D’Cruz N. et al. Neural underpinnings of freezing-related dynamic balance control in people with Parkinson’s disease. Parkinsonism & Related Disorders. 2023; 112: 105444. https://doi.org/10.1016/j.parkreldis.2023.105444
  7. Chen R., Berardelli A., Bhattacharya A. et al. Clinical neurophysiology of Parkinson’s disease and parkinsonism. Clinical Neurophysiology Practice. 2022; 7: 201–227. https://doi.org/10.1016/j.cnp.2022.06.002
  8. Wang Y., Witchalls J., Preston E. et al. The Relationship Between Ankle Proprioception and Functional Mobility in People with Parkinson’s Disease: A Cross-Sectional Study. Frontiers in Neurology. 2020; 11. https://doi.org/10.3389/fneur.2020.603814
  9. Kulisevsky J. Pharmacological management of Parkinson’s disease motors symptoms: update and recommendation from expert. Rev Neurol. 2022; 75(s04): 1–10. https://doi.org/10.33588/rn.75s04.2022217
  10. Surisetti B.K., Prasad S., Holla V.V. et al. Movement disorders associated with radiotherapy and surgical procedures. J Mov Disord. 2023; 16(1): 42–51. https://doi.org/10.14802/jmd.22092 (Epub 2023 Jan 12.)
  11. Osborne J.A., Botkin R., Colon-Semenza C. et al. Physical therapist management of Parkinson disease: a clinical practice guideline from the American Physical Therapy Association. Phys Ther. 2022; 102(4): 302. https:// doi.org/10.1093/ptj/pzab302
  12. WHO guidelines on physical activity and sedentary behavior. WHO. 2020. https://www.who.int/publications-detail-redirect/9789240015128 (accessed on:17.06.2023)
  13. Schootemeijer S., van der Kolk N.M., Bloem B.R., de Vries N.M. Current perspectives on aerobic exercise in people with Parkinson’s disease. Neurotherapeutics.2020; 17(4): 1418–1433. https://doi.org/10.1007/s13311-020-00904-8
  14. Gonçalves H.R., Rodrigues A.M., Santos C.P. Vibrotactile biofeedback devices in Parkinson’s disease: a narrative review. Medical & Biological Engineering & Computing. 2021; 59(6): 1185–1199. https://doi.org/10.1007/s11517-021-02365-3
  15. Agarwala P., Salzman S.H. Six-Minute Walk Test. Chest. 2020; 157(3): 603–611. https://doi.org/10.1016/j.chest.2019.10.014
  16. Urso D., van Wamelen D.J., Batzu L. et al. Clinical trajectories and biomarkers for weight variability in early Parkinson’s disease. NPJ Parkinson’s Disease. 2022; 8: 95. https://doi.org/10.1038%2Fs41531-022-00362-3
  17. Csoti I., Jost W.H., Reichmann H. Parkinson´s disease between internal medicine and neurology. J Neural Transm. 2016; 123(1): 3–17. https://doi.org/10.1007/s00702-015-1443-z
  18. Mollenhauer B., Zimmermann J., Sixel-Döring F. et al. Baseline predictors for progression 4 years after Parkinson’s disease diagnosis in the De Novo Parkinson Cohort (DeNoPa). Mov Disorder. 2019; 34(1): 67–77. https://doi.org/10.1002/mds.27492



Creative Commons License
The content is available under the Creative Commons Attribution 4.0 License.

©

Эта статья открытого доступа по лицензии CC BY 4.0. Издательство: ФГБУ «НМИЦ РК» Минздрава России.
This is an open article under the CC BY 4.0 license. Published by the National Medical Research Center for Rehabilitation and Balneology.